ResMed Inc.

NYSE:RMD

Medical - Devices

Healthcare
$242.61 +0.85%

+$1.58 today

Market cap
$34.12B
Beta
0.78
P/E (TTM)
18.1
EPS (TTM)
$10.37
Dividend yield
1.28%
52W Low $180.27High $293.81

Volume 1.22M

Average 1.32M

RMD Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

ResMed Inc.NYSE: RMD

Weighted Avg Shares (Diluted) · Q4 FY2026 · quarter ended Jun 2026

Weighted avg shares (diluted) declines year over year

Q4 FY2026 weighted avg shares (diluted) of 144.98M shares fell 1.4% year over year, behind the -0.6% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 1.4% from the prior quarter. Over 3 fiscal years it compounded at -0.6% a year.

Context

  • Weighted avg shares (diluted) increased in 1 of the last 3 fiscal years.
  • FY2026 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly growth recovers from -1.4% toward the trailing-twelve-month pace of -0.6%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
144.98M-1.4% QoQ
Last fiscal yearJun 2026
144.98M-1.6% YoY
LTMJun 2026
146.52M-0.6% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-1.4%——
1 year-1.6%——
3-year CAGR-0.6%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2026
144.98M USD
Year-over-year change
-1.6%
4-year CAGR
-0.4%

Weighted Avg Shares (Diluted) vs competitors

How RMD compares with its peers on the latest reported figures

  • RMD's LTM Jun 2026 weighted avg shares (diluted) of 146.52M shares is the 6th highest of the 9 companies compared; the peer median is 407.32M shares.
  • Its year-over-year change of -0.6% is the 5th highest of 9, against a peer median of -1.0%.
  • Over three fiscal years its annual growth of -0.6% compares with a peer median of +0.2%.
RMD Competitors Peer median
Weighted Avg Shares (Diluted) for RMD and competitors
Company Period LTM YoY 3-year CAGR
BSXBoston Scientific CorporationLTM Jun 20261.49B +0.1%+1.3%
MDTMedtronic plcLTM Jul 20261.29B +0.0%-1.1%
PHGKoninklijke Philips N.V.LTM Jun 2026966.72M +3.5%+0.4%
GEHCGE HealthCare Technologies Inc.LTM Jun 2026457.07M -0.4%+0.5%
ISRGIntuitive Surgical, Inc.LTM Sep 2026357.58M -1.7%+0.1%
RMDResMed Inc.LTM Jun 2026146.52M -0.6%-0.6%
TFXTeleflex IncorporatedLTM Jun 202644.1M -4.8%-1.9%
INSPInspire Medical Systems, Inc.LTM Jun 202629.11M -3.9%+2.0%
ELMDElectromed, Inc.LTM Mar 20268.68M -3.2%-0.2%
Peer median (excluding RMD) 407.32M-1.0%+0.2%

Competitors are the stored peer set for RMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
FY2026
Jun 2026
Revenue3.58B4.22B4.69B5.15B5.65B
Cost of Revenue1.55B1.87B2.03B2.09B2.2B
Gross Profit2.02B2.36B2.66B3.05B3.45B
Gross Margin56.6%55.8%56.7%59.4%61.1%
Research & Development253.58M287.64M307.53M331.28M378.29M
Selling, General & Admin739.37M874M917.14M991.02M1.12B
Operating Expenses1.02B1.22B1.34B1.37B1.54B
Depreciation & Amortization193.84M197.56M216.21M235.81M244.15M
EBITDA1.18B1.36B1.53B1.91B2.15B
EBITDA Margin32.9%32.2%32.7%37.2%38.1%
Operating Income1B1.13B1.32B1.69B1.91B
Operating Margin28.0%26.8%28.2%32.7%33.8%
Interest Income00000
Interest Expense22.31M47.38M45.71M12.61M0
Other Income / Expenses(39.8M)(30.21M)(55.1M)(7.8M)10.96M
Income Before Tax960.48M1.1B1.26B1.68B1.92B
Pre-Tax Margin26.8%26.1%27.0%32.6%34.0%
Income Tax Expense181.05M204.11M243.85M276.84M396.12M
Net Income779.44M897.56M1.02B1.4B1.52B
Net Margin21.8%21.3%21.8%27.2%26.9%
EPS (Basic)5.346.126.949.5510.44
EPS (Diluted)5.306.096.929.5110.40
Weighted Avg Shares146.07M146.77M147.02M146.72M144.71M
Weighted Avg Shares (Diluted)147.04M147.46M147.55M147.34M144.98M

ResMed Inc.

NYSE:RMD

Intrinsic Alpha fair value

Locked

Current Price

$242.61

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.